BlackRock Virginia Municipal Bond Trust (BHV) Stock Price

10.36 ▲ +0.14 (+1.37%)
Open: 10.36 Vol: 3.15K Day's range: 10.17 - 10.36 Mar 31, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BHV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 10.35▲ 10.36▲ 10.36▲ 10.29▲ 10.52▼
MA10 10.49▼ 10.52▼ 10.52▼ 10.44▼ 10.64▼
MA20 10.61▼ 10.63▼ 10.63▼ 10.58▼ 10.69▼
MA50 10.63▼ 10.67▼ 10.68▼ 10.66▼ 10.59▼
MA100 10.86▼ 10.79▼ 10.75▼ 10.76▼ 10.83▼
MA200 10.74▼ 10.82▼ 10.85▼ 10.65▼ 11.02▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.037▼ -0.040▼ -0.040▼ -0.042▼ -0.049▼
RSI 34.244▼ 32.746▼ 32.836▼ 39.166▼ 40.276▼
STOCH 0.505▼ 3.757▼ 3.757▼ 22.265     43.702    
WILL %R -97.980▼ -97.980▼ -97.980▼ -65.217     -67.367    
CCI -76.811     -92.923     -92.923     -86.765     -163.238▼
Latest Filters Detected On BHV
▲ RSI $BHV RSI(14) Crossed Above 30 Set Alert
MA $BHV Price Crossed Above MA(7) Set Alert
CDL $BHV Hanging Man Candlestick Pattern Detected Set Alert
CDL $BHV Doji Candlestick Pattern Detected Set Alert
BlackRock Virginia Municipal Bond Trust News
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2025 Financial Results
Monday, March 02, 2026 01:05 PM
Prioritizing three key, late-stage clinical programs including Molecular Degrader of Extracellular Proteins (MoDETM) and Targeted Removal of Aberrant Protein (TRAPTM) extracellular protein degradation ...
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Monday, January 12, 2026 08:15 AM
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE™ and next-generation, highly selective TRAP™ ...
What's Going On With Biohaven Stock Friday?
Friday, December 26, 2025 05:12 AM
Biohaven Ltd. (NYSE: BHVN) shares were trading lower Friday but have since flattened after the company announced its Phase 2 proof-of-concept study of BHV-7000 in major depressive disorder failed to ...
BHV historical stock data
date open high low close volume
31/03/26 10.36 10.36 10.17 10.36 3,152
30/03/26 10.32 10.32 10.04 10.22 9,905
27/03/26 10.37 10.37 10.2701 10.2701 7,887
26/03/26 10.33 10.33 10.33 10.33 444
25/03/26 10.46 10.46 10.28 10.29 3,000
24/03/26 10.50 10.50 10.455 10.455 265
23/03/26 10.55 10.5899 10.43 10.55 7,069
20/03/26 10.62 10.62 10.25 10.59 10,584
19/03/26 10.68 10.68 10.68 10.68 3
18/03/26 10.62 10.66 10.62 10.66 300
Quote Details
52wk Low:10.01
52wk High:11.66
Vol:3.15K
Avg Vol(3m):96.7K
1Y Chng:+0.39%
1M Chng:-3.63%
Add to Watch List
More Information
Index N/A
Market Cap. 16.23M